AUPH - Aurinia Pharmaceuticals

-

$undefined

N/A

(N/A)

Aurinia Pharmaceuticals NASDAQ:AUPH Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

Location: 1203-4464 Markham St, British Columbia, V8Z 7X8, Canada | Website: www.auriniapharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

826.7M

Cash

330.3M

Avg Qtr Burn

-430K

Short % of Float

5.59%

Insider Ownership

7.07%

Institutional Own.

44.47%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.